What changed
Pfizer's board unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, after she served as Interim CFO since August 16, 2026. Her compensation includes an annual base salary of $1,300,000 and an annual target cash incentive opportunity of $1,300,000, equal to 100% of base salary. Guegan, 55, has more than 25 years of global finance leadership in the pharmaceutical industry and previously served as Senior Vice President of Finance for Pfizer's Global Biopharmaceuticals business since 2022.
Why it matters
Pfizer's board unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, after she served as Interim CFO since August 16, 2026. Her compens